Environmental factors and drug trials. 3. A pilot study of the social structure of psychiatric hospital wards during a drug trial.

Environmental factors and drug trials. 3. A pilot study of the social structure of psychiatric hospital wards during a drug trial. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Environmental factors and drug trials. 3. A pilot study of the social structure of psychiatric hospital wards during a drug trial. Abstract Text:

C Perris,W Rapp,O Román,

Environmental factors and drug trials. 3. A pilot study of the social structure of psychiatric hospital wards during a drug trial. Publishing Authors By Initials

C Perris,W Rapp,O Román,

For similar geographic locations: europe: scandinavia: sweden research abstracts see: geographic locations: europe: scandinavia: sweden research

PUBMED ID PMID:

MEDLINE DATE:

Environmental factors and drug trials. 3. A pilot study of the social structure of psychiatric hospital wards during a drug trial. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Acta psychiatrica Scandinavica. Supplementum

VOLUME: 249

Page Numbers: 28-37

Journal Abbreviation:

ISSN: 0065-1591

DAY: 15

MONTH: 02

YEAR: 1974

Environmental factors and drug trials. 3. A pilot study of the social structure of psychiatric hospital wards during a drug trial. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370365

Environmental factors and drug trials. 3. A pilot study of the social structure of psychiatric hospital wards during a drug trial. Keywords Mesh Terms:

KEYWORDS: Sweden

MESH TERMS:

Chemical & Substance for Abstract: Environmental factors and drug trials. 3. A pilot study of the social structure of psychiatric hospital wards during a drug trial. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Environmental factors and drug trials. 3. A pilot study of the social structure of psychiatric hospital wards during a drug trial.

AFFILIATION:

Country: DENMARK

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Acta Psychiatr Scand Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Environmental factors and drug trials 3 A pilot study of the social structure of psychiatric hospital wards during a drug trial Related Publications

• Acrylic injectable and self-curing formulations for the local release of bisphosphonates in bone tissue.
• Alveolar type II cells from ethanol-fed rats produce a fibronectin-enriched extracellular matrix that promotes monocyte activation.
• Autism: transient in utero hypothyroxinemia related to maternal flavonoid ingestion during pregnancy and to other environmental antithyroid agents.
• Black thyroid syndrome.
• Bronchoalveolar lavage fluid D dimer levels are higher and more prevalent in black patients with pulmonary sarcoidosis.
• Controlled-release oxycodone admissions in public and private substance abuse treatment: associations with organizational characteristics.
• Counselor emotional exhaustion and turnover intention in therapeutic communities.
• Editorial commentary.
• Effects of latanoprost, timolol and GLC756, a novel dopamine D(2) agonist and D(1) antagonist on LTC(4) release after rat mast cell activation.
• Elevations in renal interstitial hydrostatic pressure and 20-hydroxyeicosatetraenoic acid contribute to pressure natriuresis.
• Environmental neurology: a promising new field of practice and research.
• Environmental vascular risk factors: new perspectives for stroke prevention.
• Exploratory activity in Drosophila requires the kurtz nonvisual arrestin.
• Extracellular cysteine/cystine redox potential controls lung fibroblast proliferation and matrix expression through upregulation of transforming growth factor-beta.
• Increased fibronectin expression in lung in the setting of chronic alcohol abuse.
• Mouse smad8 phosphorylation downstream of BMP receptors ALK-2, ALK-3, and ALK-6 induces its association with Smad4 and transcriptional activity.
• Nicotine alters lung branching morphogenesis through the alpha7 nicotinic acetylcholine receptor.
• Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
• Racial and ethnic disparities in SSRI availability in substance abuse treatment.
• Referral pathways and diagnosis: UK government actions fail to recognize complexity of lymphoma.
• Research network involvement and addiction treatment center staff: counselor attitudes toward buprenorphine.
• Research participation and turnover intention: An exploratory analysis of substance abuse counselors.
• Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier.
• Roman tunnelling tool.
• The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters.
• The effects of caffeine on the preterm sheep ductus arteriosus.
• The selfless geneticist.
• The use of antidepressant medications in substance abuse treatment: the public-private distinction, organizational compatibility, and the environment.
• Trends in the adoption of medications for alcohol dependence.
• [Neurocysticercosis: a public health perspective]